WRGCX Mutual Fund

WRGCX Mutual Fund

NAV$20.87
See how much of WRGCX you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free

Fund Essentials - as of Aug 31, 2026

Net Assets
$12M
Expense Ratio
1.85%
Dividend Yield (Current)
-
Holdings
93
Inception Date
Sep 21, 1992
Fund Family
Nomura Asset Management Co Ltd
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Annually

Performance

YTD+7.68%
1 Year+8.16%
3 Year+17.80%
5 Year+1.18%
10 Year+8.75%

Asset Allocation

Stocks: 98.83%
Cash: 1.17%
See how much of WRGCX you already own
Your funds unpacked, overlap, fees and score, free on screen. The full report comes with FundXLS. Download sample.
X-ray my portfolio free

Top Holdings

View All →
TickerNameWeight
TARSTarsus Pharmaceuticals Inc2.19%
WTWisdomtree Investments Inc2.17%
TVTXTravere Therapeutics Inc2.09%
EHCEncompass Health Corp1.99%
KTBKontoor Brands Inc1.97%
Top 10 Concentration: 19.35%Report Date: Aug 31, 2026
Download all 93 holdings for WRGCX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Frequency
Annually
Latest Distribution
$6.00
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO

WRGCX Mutual Fund Overview

WRGCX Mutual Fund (Nomura Small Cap Growth Fund Class C) is managed by Nomura Asset Management Co Ltd with $12.4M in net assets. WRGCX expense ratio is 1.85%, holding 93 positions across sectors including Health Care, Information Technology, Industrials. Inception date: 1992-09-21.

WRGCX performance shows a YTD return of 7.68%. The 1-year return is 8.16% and the 5-year return is 1.18%.

WRGCX top holdings include Tarsus Pharmaceuticals Inc (2.2%), Wisdomtree Investments Inc (2.2%), Travere Therapeutics Inc (2.1%), Encompass Health Corp (2.0%), Kontoor Brands Inc (2.0%). Go to all WRGCX holdings, WRGCX sectors, or WRGCX dividends.

WRGCX can be compared against other funds. Use WRGCX overlap to find shared positions, or WRGCX vs another fund for a side-by-side view. WRGCX alternatives are available via the screener, along with tax-loss harvesting opportunities.